Article

Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top news of the week from Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/biosimilar-naming-convention-debate-highlights-spe" target="_blank">View the story "Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Abstract DNA molecule helix inside red blood drop
Related Content
Exploring the Tumor Microenvironment Interactions Between Cancer Cells, TCells, and Nanoparticles in Cancer Therapy and Immunology
March 31st 2025

NCCN 2025: Managing Immune Checkpoint Inhibitor-Related Toxicities in Cancer Care

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
X-ray image of liver -- Image credit: Sebastian Kaulitzki | stock.adobe.com
March 31st 2025

BEAM-302 Receives FDA IND Clearance for AATD, a Genetic Disorder Affecting the Liver and Lungs

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Kidney dialysis displayed on tablet -- Image credit: frank | stock.adobe.com
March 28th 2025

Peritoneal Dialysis May Be Feasible, Safe Long-Term Treatment for Patients With CKD

Gillian McGovern, Associate Editor
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
March 27th 2025

Denosumab-bnht Biosimilar Receives FDA Approval

Kennedy Ferruggia, Assistant Editor